Additional Proxy Soliciting Materials (definitive) (defa14a)
April 28 2017 - 4:13PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 14A
(Rule 14a-101)
SCHEDULE 14A INFORMATION
Proxy Statement Pursuant to Section 14(a) of the
Securities Exchange Act of 1934
(Amendment No. )
Filed by the
Registrant ☒ Filed by a party other than the
Registrant ☐
Check the appropriate box:
|
|
|
☐
|
|
Preliminary Proxy Statement
|
|
|
☐
|
|
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
|
|
☐
|
|
Definitive Proxy Statement
|
|
|
☒
|
|
Definitive Additional Materials
|
|
|
☐
|
|
Soliciting Material Under §240.14a-12
|
Karyopharm
Therapeutics Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
|
|
|
|
|
|
|
☒
|
|
No fee required.
|
|
|
☐
|
|
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
|
|
|
|
(1)
|
|
Title of each class of securities to which transaction applies:
|
|
|
(2)
|
|
Aggregate number of securities to which transaction applies:
|
|
|
(3)
|
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing
fee is calculated and state how it was determined):
|
|
|
(4)
|
|
Proposed maximum aggregate value of transaction:
|
|
|
(5)
|
|
Total fee paid:
|
|
|
☐
|
|
Fee paid previously with preliminary materials.
|
|
|
☐
|
|
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement
number, or the Form or Schedule and the date of its filing.
|
|
|
|
|
|
(1)
|
|
Amount previously paid:
|
|
|
(2)
|
|
Form, Schedule or Registration Statement No.:
|
|
|
(3)
|
|
Filing party:
|
|
|
(4)
|
|
Date Filed:
|
*** Exercise Your
Right
to Vote ***
Important Notice Regarding the Availability of Proxy Materials for the
Stockholder Meeting to Be Held on June 15, 2017.
|
|
|
|
|
|
|
|
|
KARYOPHARM
THERAPEUTICS INC.
|
|
|
|
Meeting
Information
|
|
|
|
|
Meeting Type:
Annual Meeting
|
|
|
|
|
For holders as of:
April 18, 2017
|
|
|
|
|
|
Date:
June 15, 2017
Time:
8:00 AM, Eastern Time
Location:
The Sheraton Needham
Hotel
100
Cabot Street
Needham,
MA 02494
|
|
|
KARYOPHARM THERAPEUTICS INC.
C/O PROXY SERVICES
P.O. BOX 9142
FARMINGDALE, NY 11735
|
|
You are receiving this communication because
you hold shares in the company named above.
This is not a ballot. You cannot use this
notice to vote these shares. This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. You may view the proxy materials online at
www.proxyvote.com
or easily request a paper
copy (see reverse side).
We encourage you to access and review all of the important
information contained in the proxy materials before voting.
|
|
|
|
|
|
|
|
|
See the reverse side of this notice to obtain proxy materials and voting instructions.
|
|
|
|
|
|
|
|
|
|
|
|
|
Before You Vote
How to Access the Proxy Materials
Proxy Materials Available to VIEW or RECEIVE:
NOTICE AND PROXY STATEMENT ANNUAL REPORT ON FORM
10-K
How to View Online:
Have the information that is printed in the box marked by the arrow
(located on the following page) and visit:
www.proxyvote .com.
How to Request and Receive a
PAPER or
E-MAIL
Copy:
If you want to receive a paper or
e-mail
copy of these documents, you must request one. There is NO charge for requesting a copy. Please choose one of the following methods to make your request:
|
|
|
|
|
1)
BY INTERNET
:
|
|
www.proxyvote.com
|
2)
BY TELEPHONE
:
|
|
1-800-579-1639
|
3)
BY E-MAIL*
:
|
|
sendmaterial@proxyvote.com
|
|
*
|
If requesting materials by
e-mail,
please send a blank
e-mail
with the information that is printed in the box marked by the arrow
(located on the following page) in the subject line.
|
Requests,
instructions and other inquiries sent to this
e-mail
address will NOT be forwarded to your investment advisor. Please make the request as instructed above on or before June 1, 2017 to facilitate timely
delivery.
How To Vote
Please Choose One of the Following Voting Methods
|
|
|
|
|
|
|
|
|
|
Vote In Person:
Many stockholder meetings
have attendance requirements including, but not limited to, the possession of an attendance ticket issued by the entity holding the meeting. Please check the meeting materials for any special requirements for meeting attendance. At the meeting, you
will need to request a ballot to vote these shares.
Vote By
Internet:
To vote now by Internet, go to
www.proxyvote.com.
Have the information that is printed in the box marked by the arrow
(located on the following page) available and follow the instructions.
Vote By Mail:
You can vote by mail by requesting a paper copy of the materials, which will include a proxy card.
|
|
|
The Board of Directors recommends you vote
FOR each director nominee and FOR Proposal 2:
|
1.
|
Proposal to elect three Class I Director Nominees
|
Nominees:
|
03)
|
Mansoor Raza Mirza, M.D.
|
|
2.
|
Ratification of the selection of Ernst & Young LLP as the Companys independent registered public accounting firm for the fiscal year ending December 31, 2017.
|
In their discretion, the proxies are authorized to vote upon such other matters as may be properly brought before the meeting or any
adjournment thereof.
Karyopharm Therapeutics (NASDAQ:KPTI)
Historical Stock Chart
From Aug 2024 to Sep 2024
Karyopharm Therapeutics (NASDAQ:KPTI)
Historical Stock Chart
From Sep 2023 to Sep 2024